233 related articles for article (PubMed ID: 11353630)
1. Drug susceptibility testing of anaerobic protozoa.
Upcroft JA; Upcroft P
Antimicrob Agents Chemother; 2001 Jun; 45(6):1810-4. PubMed ID: 11353630
[TBL] [Abstract][Full Text] [Related]
2. Drug targets and mechanisms of resistance in the anaerobic protozoa.
Upcroft P; Upcroft JA
Clin Microbiol Rev; 2001 Jan; 14(1):150-64. PubMed ID: 11148007
[TBL] [Abstract][Full Text] [Related]
3. Drug susceptibility testing in microaerophilic parasites: Cysteine strongly affects the effectivities of metronidazole and auranofin, a novel and promising antimicrobial.
Leitsch D
Int J Parasitol Drugs Drug Resist; 2017 Dec; 7(3):321-327. PubMed ID: 28910741
[TBL] [Abstract][Full Text] [Related]
4. In vitro effect of nitazoxanide against Entamoeba histolytica, Giardia intestinalis and Trichomonas vaginalis trophozoites.
Cedillo-Rivera R; Chávez B; González-Robles A; Tapia A; Yépez-Mulia L
J Eukaryot Microbiol; 2002; 49(3):201-8. PubMed ID: 12120985
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of nitazoxanide and related compounds against isolates of Giardia intestinalis, Entamoeba histolytica and Trichomonas vaginalis.
Adagu IS; Nolder D; Warhurst DC; Rossignol JF
J Antimicrob Chemother; 2002 Jan; 49(1):103-11. PubMed ID: 11751773
[TBL] [Abstract][Full Text] [Related]
6. Metronidazole and albendazole susceptibility of 11 clinical isolates of Giardia duodenalis from France.
Lemée V; Zaharia I; Nevez G; Rabodonirina M; Brasseur P; Ballet JJ; Favennec L
J Antimicrob Chemother; 2000 Nov; 46(5):819-21. PubMed ID: 11062206
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the effects of albendazole and metronidazole on the ultrastructure of Giardia duodenalis, Trichomonas vaginalis and Spironucleus muris using transmission electron microscopy.
Oxberry ME; Thompson RC; Reynoldson JA
Int J Parasitol; 1994 Aug; 24(5):695-703. PubMed ID: 7928072
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of new 5-nitroimidazoles against metronidazole-susceptible and -resistant Giardia, Trichomonas, and Entamoeba spp.
Upcroft JA; Campbell RW; Benakli K; Upcroft P; Vanelle P
Antimicrob Agents Chemother; 1999 Jan; 43(1):73-6. PubMed ID: 9869568
[TBL] [Abstract][Full Text] [Related]
9. The activity of protease inhibitors against Giardia duodenalis and metronidazole-resistant Trichomonas vaginalis.
Dunn LA; Andrews KT; McCarthy JS; Wright JM; Skinner-Adams TS; Upcroft P; Upcroft JA
Int J Antimicrob Agents; 2007 Jan; 29(1):98-102. PubMed ID: 17137752
[TBL] [Abstract][Full Text] [Related]
10. Giardia, Entamoeba, and Trichomonas enzymes activate metronidazole (nitroreductases) and inactivate metronidazole (nitroimidazole reductases).
Pal D; Banerjee S; Cui J; Schwartz A; Ghosh SK; Samuelson J
Antimicrob Agents Chemother; 2009 Feb; 53(2):458-64. PubMed ID: 19015349
[TBL] [Abstract][Full Text] [Related]
11. Activity of disulfiram (bis(diethylthiocarbamoyl)disulphide) and ditiocarb (diethyldithiocarbamate) against metronidazole-sensitive and -resistant Trichomonas vaginalis and Tritrichomonas foetus.
Bouma MJ; Snowdon D; Fairlamb AH; Ackers JP
J Antimicrob Chemother; 1998 Dec; 42(6):817-20. PubMed ID: 10052908
[TBL] [Abstract][Full Text] [Related]
12. A comparison of two methods for assessing drug sensitivity in Giardia duodenalis.
Pearce DA; Reynoldson JA; Thompson RC
Appl Parasitol; 1996 Jun; 37(2):111-6. PubMed ID: 8688860
[TBL] [Abstract][Full Text] [Related]
13. [Investigation of in vitro metronidazole resistance in the clinical isolates of Trichomonas vaginalis].
Ertabaklar H; Yaman Karadam S; Malatyalı E; Ertuğ S
Mikrobiyol Bul; 2016 Oct; 50(4):552-558. PubMed ID: 28124960
[TBL] [Abstract][Full Text] [Related]
14. 5-Nitroimidazole drugs effective against metronidazole-resistant Trichomonas vaginalis and Giardia duodenalis.
Upcroft JA; Dunn LA; Wright JM; Benakli K; Upcroft P; Vanelle P
Antimicrob Agents Chemother; 2006 Jan; 50(1):344-7. PubMed ID: 16377707
[TBL] [Abstract][Full Text] [Related]
15. Hydrogenosomes of laboratory-induced metronidazole-resistant Trichomonas vaginalis lines are downsized while those from clinically metronidazole-resistant isolates are not.
Wright JM; Webb RI; O'Donoghue P; Upcroft P; Upcroft JA
J Eukaryot Microbiol; 2010; 57(2):171-6. PubMed ID: 20015182
[TBL] [Abstract][Full Text] [Related]
16. Use of a time-kill technique for susceptibility testing of Trichomonas vaginalis.
Krieger JN; Dickins CS; Rein MF
Antimicrob Agents Chemother; 1985 Mar; 27(3):332-6. PubMed ID: 3873214
[TBL] [Abstract][Full Text] [Related]
17. "Chemotherapeutic approaches to protozoa: Giardia, Trichomonas and Entamoeba-current level of knowledge and outlook".
Harder A
Parasitol Res; 2002 Jun; 88(6):591. PubMed ID: 12152617
[No Abstract] [Full Text] [Related]
18. Synthesis and antiprotozoal activity of some 2-(trifluoromethyl)-1H-benzimidazole bioisosteres.
Navarrete-Vázquez G; Rojano-Vilchis Mde M; Yépez-Mulia L; Meléndez V; Gerena L; Hernández-Campos A; Castillo R; Hernández-Luis F
Eur J Med Chem; 2006 Jan; 41(1):135-41. PubMed ID: 16260067
[TBL] [Abstract][Full Text] [Related]
19. Highly Potent 1
Kumar S; Bains T; Won Kim AS; Tam C; Kim J; Cheng LW; Land KM; Debnath A; Kumar V
Front Cell Infect Microbiol; 2018; 8():380. PubMed ID: 30425970
[TBL] [Abstract][Full Text] [Related]
20. Measuring the in vitro susceptibility of Trichomonas vaginalis to metronidazole: a disk broth method.
Smith RF; Di Domenico A
Sex Transm Dis; 1980; 7(3):120-4. PubMed ID: 6969450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
